Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H26O12 |
| Molecular Weight | 470.4239 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]3[C@@H]1C=C[C@]34OC(=O)C(=C4)[C@H](C)O
InChI
InChIKey=AOPMSFXOYJXDNJ-IRFSQMTFSA-N
InChI=1S/C21H26O12/c1-8(23)10-5-21(33-18(10)28)4-3-9-11(17(27)29-2)7-30-19(13(9)21)32-20-16(26)15(25)14(24)12(6-22)31-20/h3-5,7-9,12-16,19-20,22-26H,6H2,1-2H3/t8-,9+,12+,13+,14+,15-,16+,19-,20-,21+/m0/s1
| Molecular Formula | C21H26O12 |
| Molecular Weight | 470.4239 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/15357574Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12112301 | https://www.ncbi.nlm.nih.gov/pubmed/25888719
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15357574
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12112301 | https://www.ncbi.nlm.nih.gov/pubmed/25888719
Plumieride was isolated as one of the major components from the biologically active methanolic extract of the bark of Plumeria bicolor (family Apocynaceae). It possess antifungal and moderate cytotoxic effect, and demonstrates anti-malarial activity in vivo.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Anti-malarial activity and toxicity assessment of Himatanthus articulatus, a plant used to treat malaria in the Brazilian Amazon. | 2015-03-27 |
|
| Structural modifications of plumieride isolated from Plumeria bicolor and the effect of these modifications on in vitro anticancer activity. | 2004-09-17 |
|
| Plumieride from Allamanda cathartica as an antidermatophytic agent. | 2002-06 |
|
| HIV-1 and HIV-2 reverse transcriptases: a comparative study of sensitivity to inhibition by selected natural products. | 1992-05-29 |
|
| Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. | 1991-01-01 |
|
| Cytotoxic constituents of the bark of Plumeria rubra collected in Indonesia. | 1990-11-01 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15070168
In toxicology experiments, plumieride was fed to male rats orally at doses of (15 mg/rat/day) for the period of 60 days.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12112301
For anti-fungal experiment, 5 mg of of the plumieride was dissolved in 10 mL of 50% ethanol. The assay disc was impregnated with 2mL of the solution of compound prepared in 50% ethanol by repeated addition and evaporation of the solvent. For the control, discs were impregnated with 50% ethanol. The assay discs were transferred aseptically to the Petri plates containing Sabouraud dextrose agar medium. The plates were inoculated separately by the mycelial disc of the test dermatophytes, Epidermophyton floccosum and Microsporum gypseum. The plates were incubated at 28°1°C for 6 days and the colony diameter of the test dermatophytes of the treatment and control sets were measured on day 7 and the per cent inhibition of growth of test dermatophytes was calculated.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:02:34 GMT 2025
by
admin
on
Mon Mar 31 22:02:34 GMT 2025
|
| Record UNII |
71A048XW8V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m8927
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
72319
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY | |||
|
DTXSID40199109
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY | |||
|
609065
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY | |||
|
511-89-7
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY | |||
|
71A048XW8V
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY |